ILSI-Biomed Israel

Job Offers: Research Assistant

Research Assistant (Biologist) for Development Division (Job no. BBT 003) For a bio-tech company, we are looking for a Research Assistant for work with cell cultures. B.Sc. or M.Sc. in Biology/Life Sciences Previous work experience with Cell Cultures and Bioreactors High level of communications in both Hebrew and English Dwelling place between Rehovot and Beer Sheva. Please send relevant cv’s only (with the Job no.) to Rachel.Schecter@managingprosolutions.com Tweet

Low-radiation MIS Spine Surgery-Mazor Robotics at AANS and SAS 2011

Computers and robotics have evolved as the standard-of-care for certain procedures in medical specialties such as urology and gynecology. Is spine surgery undergoing the same transformation? Here is the invitation to “test drive” the Mazor Robotics SpineAssist® System and find out. Learn how SpineAssist can be easily and successfully integrated into your clinical practice. See how this cutting-edge technology is impacting your colleagues who have joined the family of SpineAssist surg...

Happy New Year!

Tweet

Perspective: Integrity in Academic Career

I think everyone who was a part of academic world on some stage of his career has something to say about integrity in this area. I invite you to contemplate on this issue and here are the two points of view. This article discribes how it should be and raises some interesting questions. And here is the comics describing how it is, at least somewhere, sometimes... So what do you think? What is the meaning of academic integrity for you personally? Tweet

May 23-25, 2011: save the date for ILSI-BioMed Israel!

Yes. It is about time to open your calendars and write down the next date: May 23-25 2011. ILSI-BioMed Israel 2011, that is. The 10th international Life Science & Technology Week is just around the corner. Time do flies... The event follows the highly successful 2010 BioMed conference which attracted more than 6000 participants from 51 countries. What an event! ILSI-BioMed 2011 will present high-quality program, featuring top-notch industry executives. Israel's most innovative medi...

Introducing: the 1st ever Virtual Bio-Med

So you missed this one... You were on vacation, your aunt dropped by for a visit. You missed it. No worry! For a one time fee, you can now view nearly 100 of ILSI-BioMed 2010's most important sessions. Following a short registration on site, sessions will be available for an unlimited amount of time - on one computer. Viewers in Israel: http://biomedisrael.newtonstrand.com/ All other viewers: http://biomed.newtonstrand.com/

Aiming for Near-Normal Blood Sugar Did Not Delay Combined Risk of Diabetic Damage for People With Long-standing Diabetes, NIH-Sponsored Trial Finds

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found.  The intensive glucose treatment was compared with standard glucose control. These findings are from the NIH-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.  Although intensive t...

Long-Awaited Bilski Decision Expected Soon

by GERSON PANITCH, FINNEGAN   June 14, 2010 Patent professionals and U.S. Supreme Court watchers alike on high alert as a Bilski decision is expected before the Court’s 2009 term comes to an end this month.  Perhaps no case is more anticipated than the decision in Bilski v. Doll, especially for those in high-tech fields such as telecom, software, and professional services.  Over a year has passed since the Supreme Court agreed to hear Bilski’s appeal (June 1, 2009), and more than seven ...

BioMed 2010: Merck-Serono reaches out to collaborate with Israeli companies and entrepreneurs

BioMed 2010: Merck-Serono reaches out to collaborate with Israeli companies and entrepreneurs This is done through Inter-lab is the company's R&D center in Israel • Inter-Lab CEO, Regine Shevach: "The Israeli science has a special zest to it, one which we are thrilled to encounter time and time again; Together with Merck Serono, this special zest can create the next blockbuster drug…" Merck Serono, the largest biotechnology company in Europe, is calling on Israeli entrepreneurs and comp...

ILSI-BioMed 2010 Has Begun!

This morning the ILSI-BioMed Week 2010 has finally been launched, with 7,000 anticipated participants that will take part in lectures and meetings with the experts and seniors of the bio-pharma and medical equipment industry in Israel and abroad. Following the opening words of the event's organizers, ILSI and Kenes, the president of Israel Shimon Peres came up to the stage and surveyed the future of Israel, which will be based on advanced technologies and serve as an example to the entire...